Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound preparation of Azithromycin and Pidotimod

A technology of azithromycin and pidotimod, applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, antibacterial drugs, etc., to achieve good safety, little impact on liver function, increase phagocytic activity and chemotaxis Effect

Inactive Publication Date: 2005-01-12
SUNSTONE TANGSHAN PHARM CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, an increasing number of infected patients have failed to achieve the desired effect after antibiotic treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound preparation of Azithromycin and Pidotimod

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0023] Embodiment sees the following table:

[0024] Table 1 Example

[0025]

[0026] Further illustrate effect of the present invention below by curative effect report.

[0027] The purpose of reporting the efficacy of pidotimod and azithromycin compound preparations in the treatment of community-acquired pneumonia

[0028] Observe and compare whether there is any difference in clinical curative effect between the azithromycin group alone and the compound preparation treatment group of the present invention in patients with community-acquired pneumonia (CAP).

[0029] Materials and Methods

[0030] 1. Clinical data: 68 patients who were clinically diagnosed as CAP were selected for treatment. The diagnostic criteria were based on the "Guidelines for the Diagnosis and Treatment of Community Acquired Pneumonia (Draft)" formulated by the Respiratory Branch of the Chinese Medical Association, and severe liver, kidney and tumor diseases were exclud...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A compound medicine for treating infectious diseases is prepared from azimycin and Piduomode.

Description

technical field [0001] The invention relates to a compound preparation of azithromycin and pidotimod for treating infectious diseases. Background technique [0002] Since 1928, with the discovery and utilization of antibiotics represented by penicillin, breakthroughs have been made in anti-infection therapy. In recent decades, hundreds of antibiotics have been launched one after another, providing an effective weapon for solving bacterial infectious diseases. (Currently, the pathogens that cause infectious diseases are still mainly bacteria.) It is also because of this that the role and value of the immune function of the human body in anti-infection are ignored. In recent years, more and more infected patients failed to achieve the desired effect after antibiotic treatment. The patient is very prone to infection or repeated attacks of infection, and the prognosis is poor. Excluding the factors of viral infection and rational application of antibiotics, whether the patien...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K38/05A61P31/04A61P37/02
Inventor 韩志强贾晓冬
Owner SUNSTONE TANGSHAN PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com